Metabolic and receptor imaging of metastatic medullary thyroid cancer: does anti-CEA and somatostatin-receptor scintigraphy allow for prognostic predictions?
Behr
T M
TM
Becker
W
W
D000368:Aged; D002272:Carcinoembryonic Antigen / Q000276:immunology*; D018276:Carcinoma, Medullary / Q000000981:diagnostic imaging* / Q000556:secondary*; D006801:Humans; D008297:Male; D015282:Octreotide; D011379:Prognosis; D016719:Radioimmunodetection; D017481:Receptors, Somatostatin / Q000032:analysis*; D012680:Sensitivity and Specificity; D013964:Thyroid Neoplasms / Q000473:pathology*
D002272:Carcinoembryonic Antigen; D017481:Receptors, Somatostatin; D015282:Octreotide